Vyleesi autoinjector?

Vyleesi® (paliperidone palmitate) – Autoinjector

Vyleesi is a long‑acting injectable antipsychotic used mainly for the treatment of schizophrenia. It’s delivered once a month (or every two months, if the patient has been on the medication for at least 3 months). The drug is formulated as a palmitate ester of paliperidone, which slowly releases the active compound from the intramuscular depot.

---

1. How the Autoinjector Works

Feature	Detail
Device type	Pre‑filled autoinjector (pen‑style).
Dose strength	234 mg of paliperidone palmitate per injection (available in a 4 mL solution).
Injection site	Gluteal muscle (but can also be administered in the thigh for patients who can’t use the glute).
Injection depth	10 mm (auto‑adjusts for adult body habitus).
Actuation	Single button push releases the dose.
Safety	Integrated needle guard protects against accidental needle sticks.

---

2. Typical Dosing Schedule

Stage	Dose	Frequency
Loading phase (first 4 weeks)	234 mg on Day 1, Day 15, Day 29	1 month
Maintenance	156 mg monthly (or 234 mg every 2 months for patients who have tolerated 156 mg for ≥3 months)	1 month or 2 months

Note: The 156 mg dose is not available in an autoinjector; it is given with a syringe. The autoinjector is specifically for the 234 mg “loading” dose.

---

3. How to Use the Autoinjector

1. Check the packaging.
   • Verify the dose printed on the cartridge (should say 234 mg).
   • Inspect for any damage or foreign objects.

2. Prepare the injection site.
   • Choose a gluteal site: the upper outer quadrant of the buttock.
   • Clean the area with an alcohol wipe; allow to dry.

3. Remove the needle guard.
   • Slide the guard off the needle, keeping your fingers away from the sharp tip.

4. Attach the autoinjector to the patient.
   • Place the tip of the needle into the injection site.
   • Keep the device steady.

5. Activate the injection.
   • Press the button firmly until you feel the “click.”
   • Hold the button for 3 seconds to ensure the full dose is delivered.

6. Remove the needle.
   • Pull the needle away while keeping the device at a 45° angle.
   • Replace the needle guard before disposal.

7. Dispose of the device.
   • Use a puncture‑proof sharps container.

8. Post‑injection care.
   • Monitor the site for redness, swelling, or pain.
   • Report any severe or prolonged reactions to your clinician.

---

4. Common Side Effects

System	Common reactions
Metabolic	Weight gain, increased appetite, hyperglycemia, dyslipidemia.
Extrapyramidal	Akathisia, tremor, dystonia, Parkinsonism.
Endocrine	Hyperprolactinemia (may cause galactorrhea, menstrual changes).
Injection site	Pain, swelling, bruising, rare abscess.
Other	Sedation, dizziness, orthostatic hypotension.

What to watch for: Severe agitation, chest pain, rapid heartbeat, or symptoms of neuroleptic malignant syndrome (high fever, rigidity, autonomic instability) require immediate medical attention.

---

5. Contraindications & Precautions

Category	Key Points
Allergy	Avoid if known hypersensitivity to paliperidone or any component.
Pregnancy/Lactation	Use only if clearly needed; no sufficient data on safety.
Renal/Liver impairment	Dose adjustment may be needed; monitor for accumulation.
Cardiovascular	Monitor QT interval; avoid with drugs that prolong QT.
Diabetes	Screen for metabolic syndrome; adjust diet and exercise.
Psychosis	Not for acute agitation; requires oral conversion first.

---

6. Drug Interactions

Drug	Interaction
CYP3A4 inhibitors (e.g., ketoconazole, ritonavir)	↑paliperidone levels → ↑side effects.
CYP3A4 inducers (e.g., rifampin, carbamazepine)	↓paliperidone levels → ↓efficacy.
Anticholinergics (e.g., diphenhydramine)	↑extrapyramidal symptoms.
Other antipsychotics	Additive sedation/weight gain.

---

7. Storage & Handling

Item	Conditions
Autoinjector	2 °C to 30 °C (ambient). Do not freeze.
Syringes (156 mg)	2 °C to 25 °C.
Expired	Discard as per sharps disposal guidelines.

---

8. What to Tell Your Patient

1. Stick to the schedule. Missing injections can lead to relapse.
2. Watch for metabolic changes. Keep a log of weight and fasting glucose.
3. Report injection site pain that persists >48 h.
4. Call your prescriber if you notice any severe side effects.
5. Keep the device sealed until you are ready to use it.

---

Quick Reference – “First‑Day” Checklist

Step	Do?
Check dose label	✔
Verify injection site	✔
Remove needle guard	✔
Inject 234 mg	✔
Dispose safely	✔
Note any reaction	✔

---

Bottom Line

Vyleesi® autoinjector is a convenient, once‑monthly option for patients with schizophrenia who require steady, long‑acting antipsychotic coverage. It offers a predictable pharmacokinetic profile but requires diligent monitoring for metabolic and injection‑site effects. Always follow your clinician’s instructions and report any concerns promptly.